番紅O是一種可以和多中陰離子結合的陽離子染料，對嗜堿性的軟骨基質、核酸和木質化細胞壁等均有著色作用。它常與固綠搭配用于成骨軟骨區分染色，亦可用于纖維素細胞壁和木質化細胞壁區分。除此之外也可和阿利新藍搭配用于肥大細胞染色。

我司番紅O染色液（1%）使用高純度精選原料，雜質少保質期長。可用于單獨染色，亦可根據客戶需求搭配其他試劑用于軟骨區分染色、木質化區分染色和肥大細胞染色等多種實驗設計。該試劑僅用于科研領域，不適用于臨床診斷或其他用途。

【本資料源自公開渠道，如需（此處）屏蔽，請聯系刪除】

標題:Single-cell RNA sequencing reveals the impact of mechanical loading on knee tibial cartilage in osteoarthritis

成員:Junjie Wang, Zewen Sun, Chenghao Yu, Haibo Zhao, Mingyue Yan, Shenjie Sun, Xu Han, Tianrui Wang, Tengbo Yu, Yingze Zhang

論文因子:5.6 發表期刊:INTERNATIONAL IMMUNOPHARMACOLOGY pmid:38224628

【本資料源自公開渠道，如需（此處）屏蔽，請聯系刪除】

標題:MiR-146b-5p enriched bioinspired exosomes derived from fucoidan-directed induction mesenchymal stem cells protect chondrocytes in osteoarthritis by targeting TRAF6

成員:Lou Chao, Jiang Hongyi, Lin Zhongnan, Xia Tian, Wang Weidan, Lin Chihao, Zhang Zhiguang, Fu Haonan, Iqbal Shoaib, Liu Haixiao, Lin Jian, Wang Jilong, Pan Xiaoyun, Xue Xinghe

論文因子:10.2 發表期刊:JOURNAL OF NANOBIOTECHNOLOGY pmid:38105181

【本資料源自公開渠道，如需（此處）屏蔽，請聯系刪除】

標題:Supramolecular Integration of Multifunctional Nanomaterial by Mannose-Decorated Azocalixarene with Ginsenoside Rb1 for Synergistic Therapy of Rheumatoid Arthritis

成員:Shihui Li, Juan-Juan Li, Ying-Ying Zhao, Meng-Meng Chen, Shan-Shan Su, Shun-Yu Yao, Ze-Han Wang, Xin-Yue Hu, Wen-Chao Geng, Wei Wang, Ke-Rang Wang, Dong-Sheng Guo

論文因子:17.1 發表期刊:ACS Nano pmid:38096153

【本資料源自公開渠道，如需（此處）屏蔽，請聯系刪除】

標題:Hollow manganese dioxide-chitosan hydrogel for the treatment of atopic dermatitis through inflammation-suppression and ROS scavenging

成員:Wu Yaguang, Zhou Zihao, Zhang Min, Li Song, Sun Mengyi, Song Zhiqiang

論文因子:10.2 發表期刊:JOURNAL OF NANOBIOTECHNOLOGY pmid:37978544

【本資料源自公開渠道，如需（此處）屏蔽，請聯系刪除】

標題:Rutaecarpine ameliorates osteoarthritis by inhibiting PI3K/AKT/NF 百B and MAPK signalling transduction through integrin 汐V汕3

成員:Junlai Wan, Mengwei Li, Xi Yuan, Xiaojun Yu, Anmin Chen, Ming Shao, Hao Kang, Peng Cheng

論文因子:5.4 發表期刊:INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE pmid:37654229

注意：以上文獻 僅供參考

番紅O染色液(1%) 477-73-6

番紅O染色液(1%) 477-73-6